I think you should. I am also invested in cldx (at $2.7 share price), and ECYT to me looks like a very similar company to the under appreciated version of CLDX. Great science, targeted therapy. They didn't get on the whole immunotherapy wave that lifted many stocks including cldx (since they aren't immunotherapy company). But there is money to be made.